BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32149579)

  • 1. No effect of vitamin D supplementation on metabolic parameters but on lipids in patients with type 2 diabetes and chronic kidney disease.
    Kim J; Nam JS; Kim H; Lee HS; Lee JE
    Int J Vitam Nutr Res; 2021 Sep; 91(5-6):649-658. PubMed ID: 32149579
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes.
    Ryu OH; Chung W; Lee S; Hong KS; Choi MG; Yoo HJ
    Korean J Intern Med; 2014 Sep; 29(5):620-9. PubMed ID: 25228838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease.
    Kim SM; Choi HJ; Lee JP; Kim DK; Oh YK; Kim YS; Lim CS
    J Ren Nutr; 2014 Jan; 24(1):20-5. PubMed ID: 24216258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Double-Blind Placebo-Controlled Trial Evaluating the Efficacy of Oral Cholecalciferol in Improving Renal and Vascular Functions in Vitamin D-Deficient Patients With Type 2 Diabetes Mellitus.
    Das S; Selvarajan S; Kamalanathan S; Parameswaran S; Zachariah B
    J Diet Suppl; 2023; 20(1):44-54. PubMed ID: 34387520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of oral vitamin D
    Tahar A; Zerdoumi F; Saidani M; Griene L; Koceir EA
    Ann Biol Clin (Paris); 2018 Jun; 76(3):313-325. PubMed ID: 29661746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D.
    Samaan F; Carvalho AB; Pillar R; Rocha LA; Cassiolato JL; Cuppari L; Canziani MEF
    J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained serum 25-hydroxyvitamin D concentrations for one year with cholecalciferol supplementation improves glycaemic control and slows the decline of residual β cell function in children with type 1 diabetes.
    Panjiyar RP; Dayal D; Attri SV; Sachdeva N; Sharma R; Bhalla AK
    Pediatr Endocrinol Diabetes Metab; 2018; 2018(3):111-117. PubMed ID: 30786675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular function and cholecalciferol supplementation in CKD: A self-controlled case series.
    Kumar V; Yadav AK; Singhal M; Kumar V; Lal A; Banerjee D; Gupta KL; Jha V
    J Steroid Biochem Mol Biol; 2018 Jun; 180():19-22. PubMed ID: 29309832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecalciferol supplementation and angiogenic markers in chronic kidney disease.
    Kaur J; Kamboj K; Yadav AK; Kaur P; Kumar V; Jha V
    PLoS One; 2022; 17(6):e0268946. PubMed ID: 35657784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vitamin D3 seasonal supplementation with 1500 IU/day in north Italian children (DINOS study).
    Mazzoleni S; Magni G; Toderini D
    Ital J Pediatr; 2019 Jan; 45(1):18. PubMed ID: 30691521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study.
    Molina P; Górriz JL; Molina MD; Peris A; Beltrán S; Kanter J; Escudero V; Romero R; Pallardó LM
    Nephrol Dial Transplant; 2014 Jan; 29(1):97-109. PubMed ID: 23975842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial.
    Courbebaisse M; Alberti C; Colas S; Prié D; Souberbielle JC; Treluyer JM; Thervet E
    Trials; 2014 Nov; 15():430. PubMed ID: 25376735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study.
    Fassio A; Adami G; Rossini M; Giollo A; Caimmi C; Bixio R; Viapiana O; Milleri S; Gatti M; Gatti D
    Nutrients; 2020 May; 12(6):. PubMed ID: 32471106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease.
    Soares AE; Maes M; Godeny P; Matsumoto AK; Barbosa DS; da Silva TAF; Souza FHMO; Delfino VDA
    Life Sci; 2017 Dec; 191():175-179. PubMed ID: 29079468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised controlled trial evaluating the impact of targeted vitamin D supplementation on endothelial function in type 2 diabetes mellitus: The DIMENSION trial.
    Dalan R; Liew H; Assam PN; Chan ES; Siddiqui FJ; Tan AW; Chew DE; Boehm BO; Leow MK
    Diab Vasc Dis Res; 2016 May; 13(3):192-200. PubMed ID: 26818228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of 3-epi-25-hydroxyvitamin D levels during cholecalciferol supplementation in adults with chronic liver diseases.
    Stokes CS; Volmer DA
    Appl Physiol Nutr Metab; 2016 Dec; 41(12):1311-1317. PubMed ID: 27863206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D supplementation improves endothelial dysfunction in patients with non-dialysis chronic kidney disease.
    Zhang Q; Zhang M; Wang H; Sun C; Feng Y; Zhu W; Cao D; Shao Q; Li N; Xia Y; Tang T; Wan C; Liu J; Jin B; Zhao M; Jiang C
    Int Urol Nephrol; 2018 May; 50(5):923-927. PubMed ID: 29484540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized control trial to assess the impact of vitamin D supplementation compared to placebo on vascular stiffness in chronic kidney disease patients.
    Levin A; Perry T; De Zoysa P; Sigrist MK; Humphries K; Tang M; Djurdjev O
    BMC Cardiovasc Disord; 2014 Nov; 14():156. PubMed ID: 25381032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.
    Bucharles S; Barberato SH; Stinghen AEM; Gruber B; Piekala L; Dambiski AC; Custodio MR; Pecoits-Filho R
    J Ren Nutr; 2012 Mar; 22(2):284-291. PubMed ID: 21908203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of different vitamin D replacement strategies in patients with diabetes.
    Alam U; Chan AW; Buazon A; Van Zeller C; Berry JL; Jugdey RS; Asghar O; Cruickshank JK; Petropoulos IN; Malik RA
    J Diabetes Complications; 2014; 28(1):66-70. PubMed ID: 24139562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.